ASCO GU symposium
Interviews and expert commentary tagged “ASCO GU symposium” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds
SAN FRANCISCO—Orteronel — a non-steroidal selective inhibitor of 17,20-lyase — did not achieve a significant improvement in overall survival in 1099 patients randomised to treatment with this “a
6 February 2014
0:00